TransMedics (TMDX) Income from Continuing Operations (2018 - 2026)
TransMedics (TMDX) posted quarterly Income from Continuing Operations of 7315000.0 for Q1 2026, down 71.51% year-over-year from 25676000.0 in Q1 2025, and down 94.14% quarter-over-quarter from 124933000.0 in Q4 2025.
TransMedics (TMDX) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TransMedics' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 7315000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 71.51% year-over-year to 7315000.0; the TTM figure through Mar 2026 stood at 191449000.0 (up 1303.48% YoY), while the FY2025 annual figure was 190322000.0, up 130257.53% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 7315000.0, down from 124933000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 124933000.0 in Q4 2025, with the low at 28445000.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 1996000.0 (2023), against an average of 9058411.76.
- Peak annual rise in Income from Continuing Operations reached 1318.18% in 2024, while the deepest fall reached 1525.1% in 2024.
- TransMedics' Income from Continuing Operations stood at 6720000.0 in 2022, then jumped by 129.7% to 1996000.0 in 2023, then sank by 1525.1% to 28445000.0 in 2024, then soared by 539.21% to 124933000.0 in 2025, then plunged by 94.14% to 7315000.0 in 2026.
- Business Quant data shows TMDX's Income from Continuing Operations at 7315000.0 in Q1 2026, 124933000.0 in Q4 2025, and 24319000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 201.00 Mn |
| 10 | TransMedics | 3.22 Bn | 2.75 Bn | 113.20 Mn | 14.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.68 Mn |
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | 124.93 Mn |
| Sep 30, 2025 | 24.32 Mn |
| Jun 30, 2025 | 34.88 Mn |
| Mar 31, 2025 | 25.68 Mn |
| Dec 31, 2024 | -28.45 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -25.42 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | -6.72 Mn |
| Sep 30, 2022 | -7.43 Mn |
| Jun 30, 2022 | -11.52 Mn |
| Mar 31, 2022 | -10.56 Mn |
| Dec 31, 2021 | -12.81 Mn |
| Sep 30, 2021 | -12.96 Mn |